Skip to content

Comparison of Circumferential Pulmonary Vein Isolation Alone Versus Linear Ablation in Addition to Circumferential Pulmonary Vein Isolation for Catheter Ablation in Persistent Atrial Fibrillation: Prospective Randomized Controlled Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02721121
Enrollment
220
Registered
2016-03-28
Start date
2016-03-31
Completion date
2021-03-31
Last updated
2019-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation

Brief summary

The purpose of this study is to compare the clinical outcomes depending on catheter ablation strategy for persistent atrial fibrillation. After randomization, investigators will conduct circumferential pulmonary vein isolation alone in a group, and additional posterior box isolation and anterior linear ablation in the other group. Investigators will compare clinical recurrence rate, complication rate, and procedure time, etc.

Interventions

PROCEDURELinear ablation in addiction to circumferential pulmonary vein isolation

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patients with persistent Atrial fibrillation (20\ 80 years) * LA diameter \<55mm * patients possible to anticoagulation and anti arrhythmic drug

Exclusion criteria

* Structural cardiac disease * Contraindication to brain perfusion CT * Catheter ablation history for AF, * Cardiac surgery for AF * active internal bleeding * Impossible to anticoagulation or antiarrhythmic drug * valvular AF (MA\> GII, Mechanical valve, Mitral valve replacement) * Patients with severe medical disease * Expected survival \< 1year * Severe alcoholics, drug addiction

Design outcomes

Primary

MeasureTime frame
Recurrence of atrial fibrillation after catheter ablation12 month

Secondary

MeasureTime frame
procedure time1 day
procedure related complication rate12 month
rate of hospitalization12 month

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026